Autosomal dominant polycystic kidney disease (ADPKD)is the most common genetic kidney disease with an estimated prevalence of between 1:400 and 1:1,000. Caused by germline mutations in PKD1 (85%) or PKD2 (15%). The cardinal feature of ADPKD is the presence of multiple fluid-filled kidney cysts which enlarge over time. Cyst initiation and expansion is a complex process characterized by abnormalities in tubular cell proliferation, fluid secretion, extracellular matrix formation and cell polarity.
Currently, the three major treatment strategies are to: 1) reduce cAMP levels; 2) inhibit cell proliferation, and 3) reduce fluid secretion.
CalvetJ.P.. Molecular genetics of polycystic kidney disease.J Nephrol1998; 11: 24–30.
2.
DaniellsC., MaheshwarM., LazarouL., DaviesF., ColesG., RavineD.. Novel and recurrent mutation in the PKD1 gene
3.
Hum Genet1998; 102: 216–220.
4.
ElhamriM., MartinM., FerrierB., BaverelG.. Substate up-take and utilisation by the kidney of fed and starved rats in vivo.Renal Physiol Biochem1993; 16: 311–24.
GranthamJ.J.. The etiology, pathogenesis and treatment of autosomal dominant polycystic kidney disease: recent advances.Am J Kid Dis1996; 28: 788–803.
7.
MochizukiT., WuG., HayashiT., XenophontosS.L., VeldhuisenB.. PKD2, a gene for polycystic kidney disease that encodes an integral membrane proteine.Science1996; 272: 1339–42.
TannerG.A.. Potassium citrate/citric acid intake improves renal function in rats with polycystic kidney disease.
10.
J Am Soc Nephrol1998; 9: 1242–8.
11.
The European Polycystic Kidney Disease Consortium.The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16.Cell1994; 77: 881–94.
12.
The International Polycystic Kidney Disease Consortium: Polycystic kidney disease: the complete structure of the PKD1 gene and its protein.Cell1995; 81: 289–98.
13.
TorresV.E., MujwidD.K., WilsonD.M., HolleyK.H.. Renal cystic disease and ammoniagenesis in Han: SPRD rats.
14.
J Am Soc Nephrol1994; 5: 1193–1200.
15.
TorresV.E., BengalR.J., LitwillerR.D., WilsonD.M.. Aggravation of polycystic kidney disease in Han: SPRD rats by buthionine sulfoximine.J Am Soc Nephrol1997; 8: 1283–91.
16.
TorresV.E.. New insights into polycystic kidney disease and its treatment.Curr Opin Nephrol Hypertens1998; 7: 159–64.
17.
ViribayM., HayashiT., TelleriaD., MochizukiT.. Novel stop and frameshifting mutation in the autosomal dominant polycysticc kidney disease 2 (PKD2) gene.Hum Genet1997; 101: 229–34.
18.
XenophontosS., ConstantinidesR., HayashiT.. A translation frameshift mutation induced by a cytosine in the polycystic kidney disease 2 gene.Hum Mol Genet1997; 6: 949–52.
19.
YamaguchiT., NagaoS., KasaharaM., TakahashiH., GranthamJ.J.. Renal accumulation and escretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease.Am J Kid Dis1997; 30: 703–09.
20.
YeM., GrantM., SharmaM., ElzingaL., SwanS., TorresV.E., GranthamJ.J.. Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro.J Am Soc Nephrol1992; 3: 984–94.
